10.132.101.151

Subscribe to our mailing list

What Topic Matters Most To You?
View Privacy Policy

Joe Manchin Ignores Daughter’s Involvement in Price Gouging

Sen. Joe Manchin (D-WV) ignored a constituent’s criticism regarding his daughter Heather Bresch, the CEO of Mylan for her involvement in pricing gouging of EpiPens.

Sen. Joe Manchin (D-WV) ignored a constituent’s criticism regarding his daughter’s involvement in pricing gouging of EpiPens, which drew considerable public anger during a town hall on Friday.

In video exclusively obtained by NTK Network, Manchin discussed the high costs of drugs and importing them from other countries like Canada.

“Buy drugs where ever you want to, as long as they have been FDA approved, they’ve been inspected to make sure they are safe. I’m fine with that. I don’t have a problem with that,” Manchin told the audience.

A constituent then shouted something about the VA, which Manchin hears and responds to.

“No one sells drugs like we do. They’re twice- and three-time [as] expensive as any place in the world because of the convoluted drug pricing,” Manchin told the audience while attempting to pull something up on a mobile device.

At this point, a constituent shouted, “like the EpiPen,” and another constituent shouted, “You mean your daughter?”

Manchin ignored these remarks, electing to look at the screen on the podium in front of him.

Manchin’s daughter is Heather Bresch, the CEO of Mylan, the company responsible for drastically increasing the cost of the EpiPen, a life-saving drug for people with extreme allergic reactions.

Mylan purchased the rights to the EpiPen in 2007 and increased the cost of the product by 461 percent. Meanwhile, Bresch’s compensation increased by 671 percent.

According to NBC News:

Proxy filings show that from 2007 to 2015, Mylan CEO Heather Bresch’s total compensation went from $2,453,456 to $18,931,068, a 671 percent increase. During the same period, the company raised EpiPen prices, with the average wholesale price going from $56.64 to $317.82, a 461 percent increase, according to data provided by Connecture.